☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Luye Pharma
Luye Pharma's Rykindo (risperidone) Receives the US FDA’s Approval for the Treatment of Schizophrenia and Bipolar 1 Disorder
January 16, 2023
Luye Pharma Receives NMPA’s Approval of World First Boyoubei (biosimilar, denosumab) to Treat Postmenopausal Women with Osteoporos...
November 10, 2022
PharmaShots Weekly Snapshot (December 23-27, 2019)
December 30, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.